Predicting tissue outcome in stroke: New approaches

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 54-59

  Østergaard, Leif ^a,b   Jónsdóttir, Kristjana Ýr ^a   Mouridsen, Kim ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Acute stroke; Informatics; Stroke MRI; Tissue outcome prediction

Indexed keywords

BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN TISSUE; COST EFFECTIVENESS ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEALTH CARE COST; HUMAN; NEUROIMAGING; OXYGEN BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; OXYGEN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE;

EID: 60549102531     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328320d297     Document Type: Review

References (33)

1. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981; 12:723-725.
2. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990; 11:423-429.
3. Østergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996; 36:726-736.
4. Wu O, Østergaard L, Weisskoff RM, et al. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003; 50:164-174.
5. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309. In this prospective, randomized, double-blinded, placebo-controlled trial, alteplase was administered in the 3-6h window to 101 patients with perfusion-diffusion mismatch. Alteplase was nonsignificantly associated with lower infarct growth and significantly associated with increased reperfusion in patients who had mismatch.
6. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000; 47:462-469.
7. Fiehler J, Foth M, Kucinski T, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002; 33:79-86.
8. Sorensen AG, Copen WA, Østergaard L, et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999; 210:519-527.
9. max and TTP thresholds separating penumbra and benign oligemia are established, in good agreement with literature findings based on MR follow-up studies.
10. Butcher KS, Parsons M, MacGregor L, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005; 36:1153-1159.
11. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. Stroke 2008; 39:1621-1628. The publication involves a broad range of stroke neurologists, neuroradiologists, neuroimaging research scientists, describing a roadmap toward standardizing the use of stroke imaging.
12. Wu O, Koroshetz WJ, Østergaard L, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 2001; 32:933-942.
13. Jacobs MA, Mitsias P, Soltanian-Zadeh H, et al. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: part 2. Stroke 2001; 32:950-957.
14. Mitsias PD, Jacobs MA, Hammoud R, et al. Multiparametric MRI ISODATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques. Stroke 2002; 33:2839-2844.
15. Gottrup C, Thomsen K, Locht P, et al. Applying instance-based techniques to prediction of final outcome in acute stroke. Artif lntell Med 2005; 33:223-236.
16. Mouridsen K, Wu O, Christensen S, et al. Prediction of final outcome in acute stroke using multivariate adaptive regression splines. Proceedings of the ISMRM Twelfth Scientific Meeting; 14-16 May 2004; Kyoto, Japan.
17. Wu O, Christensen S, Hjort N, et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain 2006; 129:2384-2393. The manuscript compares risk maps in natural history and alteplase-treated patients, demonstrating the heterogeneity of infarct risk across the perfusion-diffusion mismatch. The paper demonstrates differences in initial infarct risk for salvaged tissue in the two groups, suggestive of alteplase drug efficacy.
18. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999; 9:193-201.
19. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000; 20:1276-1293.
20. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005; 36:980-985.
21. Guadagno JV, Warburton EA, Jones PS, et al. The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis 2005; 19:239-246.
22. Guadagno JV, Warburton EA, Jones PS, et al. How affected is oxygen metabolism in DWI lesions?: a combined acute stroke PET-MR study. Neurology 2006; 67:824-829; Erratum in: Neurology 2007; 68:1327.
23. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32:749-763.
24. Lee JM, Vo KD, An H, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003; 53:227-232.
25. Geisler BS, Brandhoff F, Fiehler J, et al. Blood-oxygen-level- dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006; 37:1778-1784.
26. Siemonsen S, Fitting T, Thomalla G, et al. T2' imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology 2008; 248:979-986. The authors detected T2' signal changes related to OEF in 100 consecutive patients. The presence of a T2'-ADC mismatch is a more specific predictor of infarct growth than is TTP-ADC mismatch.
27. Østergaard L, Chester DA, Weisskoff RM, et al. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999; 19:690-699.
28. Østergaard L, Sorensen AG, Chester DA, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke 2000; 31:1097-1103.
29. Perkiö J, Soinne L, Østergaard L, et al. Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005; 36:44-49.
30. Mouridsen K, Friston K, Hjort N, et al. Bayesian estimation of cerebral perfusion using a physiological model of microvasculature. Neuroimage 2006; 33:570-579.
31. Østergaard L, Chesler DA, Gjedde A, et al. Microscopic flow heterogeneity: its determination by PWI and role in cerebral oxygen metabolism. Proceed-ings of the ISMRM Ninth Scientific Meeting; 21 -27 April 2001; Glasgow, UK.
32. Mouridsen K, Jónsdóttir KÝ, Jespersen S, et al. Clinical utility of parametric perfusion estimates in prediction of final outcome in acute stroke. Proceedings of the International Society for Magnetic Resonance in Medicines 16th Scientific Meeting, Toronto, Canada; 2008. http://www.ismrm.org/08/PubMed.htm
33. Jónsdóttir KY, Hjort N, Østergaard L, et al. Comparing relative importance of MR modalities in hyper-acute and sub-acute phase using multiparametric statistical models. Proceedings of the International Society for Magnetic Resonance in Medicines 16th Scientific Meeting, Toronto, Canada; 2008. http://www.ismrm.org/08/PubMed.htm